Cross-border expansion Great Point Partners expanded from Connecticut to London, signaling readiness to support transatlantic growth in health care portfolio companies. This creates sales opportunities for solutions that ease international market entry, regulatory navigation, and cross-border logistics.

Health care focus With a dedicated health care investment thesis spanning private growth funds and a life sciences hedge fund, GPP consistently targets health care innovators. Sales opportunities exist across compliance, clinical data management, serialization, cold-chain packaging, and IP protection tailored to life sciences.

Active portfolio growth Recent acquisitions and stakes in Ionis Pharmaceuticals, Neurogene, Eutecma, Oruka Therapeutics, VetnCare, and Lyocontract indicate ongoing aggressive portfolio expansion. This suggests demand for services that support portfolio company scale, integration, and value creation strategies.

Sustainable packaging Investment in Eutecma, a provider of modular, reusable packaging for pharmaceutical cold chains, highlights interest in sustainable, compliant logistics. Potential sales fit includes packaging optimization, temperature control analytics, and sustainability certifications.

Strategic advisory access GPP leverages an executive and medical advisory board to steer investments, implying demand for strategic consulting, due diligence support, market research, and governance solutions that align with growth trajectories of health care companies.